(Q45382363)

English

Co-administration of inactivated avian influenza virus with CpG or rIL-2 strongly enhances the local immune response after intranasal immunization in chicken

scientific article published on 30 July 2009

In more languages

Statements

scholarly article

1 reference

Europe PubMed Central

PubMed publication ID

14 December 2017

Co-administration of inactivated avian influenza virus with CpG or rIL-2 strongly enhances the local immune response after intranasal immunization in chicken (English)

1 reference

Europe PubMed Central

PubMed publication ID

14 December 2017

0 references

local immune response

1 reference

based on heuristic

inferred from title

avian influenza

1 reference

based on heuristic

inferred from title

author name string

Zhang Xiaowen

1

1 reference

Europe PubMed Central

PubMed publication ID

14 December 2017

Yu Qinghua

2

1 reference

Europe PubMed Central

PubMed publication ID

14 December 2017

Zhang Xiaofei

3

1 reference

Europe PubMed Central

PubMed publication ID

14 December 2017

Yang Qian

4

1 reference

Europe PubMed Central

PubMed publication ID

14 December 2017

language of work or name

0 references

publication date

30 July 2009

1 reference

Europe PubMed Central

PubMed publication ID

14 December 2017

1 reference

Europe PubMed Central

PubMed publication ID

14 December 2017

27

1 reference

Europe PubMed Central

PubMed publication ID

14 December 2017

41

1 reference

Europe PubMed Central

PubMed publication ID

14 December 2017

5628-5632

1 reference

Europe PubMed Central

PubMed publication ID

14 December 2017

Is virulence of H5N2 influenza viruses in chickens associated with loss of carbohydrate from the hemagglutinin?

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2009.07.023

7 January 2021

Upper Respiratory Tract Immunity

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2009.07.023

7 January 2021

The ovine nasal mucosa: an alternative tissue site for mucosal immunization.

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2009.07.023

7 January 2021

Local immune responses following nasal delivery of an adjuvanted influenza vaccine

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2009.07.023

7 January 2021

Intranasal vaccination with ISCOMATRIX adjuvanted influenza vaccine.

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2009.07.023

7 January 2021

Immune response after adjuvant mucosal immunization of mice with inactivated influenza virus.

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2009.07.023

7 January 2021

Intranasal immunization of mice with herpes simplex virus type 2 recombinant gD2: the effect of adjuvants on mucosal and serum antibody responses

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2009.07.023

7 January 2021

Induction of systemic immune responses to measles virus synthetic peptides administered intranasally

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2009.07.023

7 January 2021

Effect of compound mucosal immune adjuvant on mucosal and systemic immune responses in chicken orally vaccinated with attenuated Newcastle-disease vaccine

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2009.07.023

7 January 2021

Intraepithelial lymphocytes and the immune system.

2 references

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2009.07.023

7 January 2021

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2009.07.023

7 January 2021

based on heuristic

inferred from DOI database lookup

Bacterial CpG-DNA activates dendritic cells in vivo: T helper cell-independent cytotoxic T cell responses to soluble proteins

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2009.07.023

7 January 2021

A combination of Flt3 ligand cDNA and CpG ODN as nasal adjuvant elicits NALT dendritic cells for prolonged mucosal immunity

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2009.07.023

7 January 2021

A contribution of mouse dendritic cell-derived IL-2 for NK cell activation

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2009.07.023

7 January 2021

The regulatory, inflammatory, and T cell programming roles of interleukin-2 (IL-2).

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2009.07.023

7 January 2021

The co-administrating of recombinant porcine IL-2 could enhance protective immune responses to PRV inactivated vaccine in pigs

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2009.07.023

7 January 2021

Mast-cell responses to pathogens.

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2009.07.023

7 January 2021

Identifiers

10.1016/J.VACCINE.2009.07.023

1 reference

Europe PubMed Central

PubMed publication ID

14 December 2017

PubMed publication ID

1 reference

Europe PubMed Central

PubMed publication ID

14 December 2017

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q45382363&oldid=2076276959"